These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11472444)

  • 1. Coronary heart disease risk assessment in diabetes mellitus--a comparison of PROCAM and Framingham risk assessment functions.
    Game FL; Jones AF
    Diabet Med; 2001 May; 18(5):355-9. PubMed ID: 11472444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.
    Game FL; Bartlett WA; Bayly GR; Jones AF
    Diabetes Obes Metab; 2001 Aug; 3(4):279-86. PubMed ID: 11520308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation.
    Ferrario M; Chiodini P; Chambless LE; Cesana G; Vanuzzo D; Panico S; Sega R; Pilotto L; Palmieri L; Giampaoli S;
    Int J Epidemiol; 2005 Apr; 34(2):413-21. PubMed ID: 15659467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.
    van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM
    Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men.
    Haq IU; Ramsay LE; Yeo WW; Jackson PR; Wallis EJ
    Heart; 1999 Jan; 81(1):40-6. PubMed ID: 10220543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
    Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
    Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of serum lipid level change on 10-year coronary heart risk distribution estimated by means of seven different coronary risk scores during one-year treatment.
    Kojić NE; Derić M; Dejanović J
    Med Pregl; 2014; 67(7-8):208-15. PubMed ID: 25151760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory-based calculation of coronary heart disease risk in a hospital diabetic clinic.
    Bayly GR; Bartlett WA; Davies PH; Husband D; Haddon A; Game FL; Jones AF
    Diabet Med; 1999 Aug; 16(8):697-701. PubMed ID: 10477217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study.
    Empana JP; Ducimetière P; Arveiler D; Ferrières J; Evans A; Ruidavets JB; Haas B; Yarnell J; Bingham A; Amouyel P; Dallongeville J;
    Eur Heart J; 2003 Nov; 24(21):1903-11. PubMed ID: 14585248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study.
    Liu J; Hong Y; D'Agostino RB; Wu Z; Wang W; Sun J; Wilson PW; Kannel WB; Zhao D
    JAMA; 2004 Jun; 291(21):2591-9. PubMed ID: 15173150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study.
    Cooper JA; Miller GJ; Humphries SE
    Atherosclerosis; 2005 Jul; 181(1):93-100. PubMed ID: 15939059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease.
    Assmann G; Schulte H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1713-24. PubMed ID: 3202078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting CHD risk in patients with diabetes mellitus.
    Yeo WW; Yeo KR
    Diabet Med; 2001 May; 18(5):341-4. PubMed ID: 11472442
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of major coronary events by coronary risk profile and silent myocardial ischaemia: prospective follow-up study of primary prevention in 72 diabetic patients.
    Torremocha F; Hadjadj S; Carrié F; Rosenberg T; Herpin D; Maréchaud R
    Diabetes Metab; 2001 Feb; 27(1):49-57. PubMed ID: 11240446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.
    Buyken AE; von Eckardstein A; Schulte H; Cullen P; Assmann G
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):230-6. PubMed ID: 17446801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications.
    Song SH; Brown PM
    Diabet Med; 2004 Mar; 21(3):238-45. PubMed ID: 15008833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?
    Stephens JW; Ambler G; Vallance P; Betteridge DJ; Humphries SE; Hurel SJ
    Eur J Cardiovasc Prev Rehabil; 2004 Dec; 11(6):521-8. PubMed ID: 15580065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of individualized coronary heart disease risk calculations in patients with diabetes mellitus.
    Lambert AP; Hunt MA; Day AP; Bayly GR; Dayan CM
    Diabet Med; 2002 Jun; 19(6):514-7. PubMed ID: 12060065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM).
    Knobel H; Jericó C; Montero M; Sorli ML; Velat M; Guelar A; Saballs P; Pedro-Botet J
    AIDS Patient Care STDS; 2007 Jul; 21(7):452-7. PubMed ID: 17651026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.